雜志介紹

Expert Review Of Anticancer Therapy雜志介紹

《Expert Review Of Anticancer Therapy》是一本以English為主的未開放獲取國(guó)際優(yōu)秀期刊，中文名稱抗癌治療專家評(píng)論，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.9，最新CiteScore 指數(shù)為5.1。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Effect of primary tumor resection on survival in patients with asymptomatic unresectable metastatic colorectal cancer: a systematic review and meta-analysis

  Author: Zhang, Chengren; Cao, Cong; Liu, Lili; Lv, Yaochun; Li, Jingjing; Lu, Jiyong; Wang, Shuai; Du, Binbin; Yang, Xiongfei

• Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer

  Author: Yang, James Chih-Hsin; Zhou, Caicun; Janne, Pasi A.; Ramalingam, Suresh S.; Kim, Tae Min; Riely, Gregory J.; Spira, Alexander, I; Piotrowska, Zofia; Mekhail, Tarek; Campelo, Maria Rosario Garcia; Felip, Enriqueta; Bazhenova, Lyudmila; Jin, Shu; Kaur, Manmit; Diderichsen, Paul M.; Gupta, Neeraj; Bunn, Veronica; Lin, Jianchang; Churchill, Eric; Mehta, Minal; Nguyen, Danny

• Efficacy and safety of anti-angiogenesis agents combined with chemoradiotherapy in the treatment of locally advanced cervical cancer: a meta-analysis of randomized controlled trials

  Author: Zou, Yihua; Si, Yue; Tong, Fangqin; Guan, Meng; Bi, Chun; Wang, Xia

• Prognostic value of the nodal yield in oral squamous cell carcinoma: a systematic review and meta-analysis

  Author: Li, Jiajia; Xu, Yubo; Zhang, Jie; Wang, Shaohai; Wang, Xiaoyu; Guo, Huayan; Miao, Guojun

英文介紹

Expert Review Of Anticancer Therapy雜志英文介紹

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches.

Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections:

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points.